Nitric oxide attenuates PI4P accumulation at the ER membrane to inhibit encephalomyocarditis virus replication

Alyssa L Gehant1, Joshua D Stafford1, Polly A Hansen1

  • 1Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Insights

Nitric oxide (NO) prevents encephalomyocarditis virus (EMCV) replication in beta cells by inhibiting phosphatidylinositol-4-phosphate accumulation, thus protecting against autoimmune diabetes onset.

Area of Science:

  • Immunology
  • Virology
  • Endocrinology

Background:

  • Picornavirus infections are linked to autoimmune diabetes (type 1 diabetes mellitus).
  • Encephalomyocarditis virus (EMCV) triggers innate immunity and cytokine production.
  • Beta cells produce nitric oxide (NO) in response to cytokines, which inhibits EMCV replication and beta cell lysis.

Purpose of the Study:

  • To elucidate the mechanism by which NO inhibits EMCV replication in beta cells.
  • To investigate the role of NO in protecting beta cells from viral-induced damage.

Main Methods:

  • Investigated the effect of NO on phosphatidylinositol-4-phosphate accumulation at the endoplasmic reticulum membrane.
  • Assessed the impact of NO on viral replication complex formation.
  • Examined the selectivity of NO's inhibitory effects on EMCV in beta cells.

Main Results:

  • NO attenuates the accumulation of phosphatidylinositol-4-phosphate at the endoplasmic reticulum membrane.
  • This inhibition prevents viral replication complex formation and viral replication.
  • These effects are selective for beta cells and linked to ATP depletion.

Conclusions:

  • NO inhibits EMCV replication by disrupting phosphatidylinositol-4-phosphate metabolism at the ER membrane.
  • This mechanism protects beta cells from viral infection and lysis.
  • NO's protective role in beta cells may have implications for preventing type 1 diabetes.